IL6 and lung cancer: In addition, we clarify that Q11 can inhibit the activation of the IL‐6/STAT3 pathway and the MAPK/ERK pathway, suggesting that Q11 regulates specific signaling pathways critical for inflammatory responses in lung cancer (Figure 7).